Article

Reality Checkers

If a statement or claim seems too good to be true, it probably is. 

If a statement or claim seems too good to be true, it probably is. When conducting online research, be sure to check unsubstantiated claims through reliable resources, such as those listed here.

Memorial Sloan-Kettering Cancer Center

“About Herbs, Botanicals & Other Products”

mskcc.org/cancer-care/integrative-medicine/about-herbs-botanicals-other-products

U.S. Food and Drug Administration

“187 Fake Cancer ‘Cures’ Consumers Should Avoid”

www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ucm171057.htm

Quackwatch

“A Special Message for Cancer Patients Seeking ‘Alternative’ Treatments”

quackwatch.org/00AboutQuackwatch/altseek.html

American Cancer Society

“Rumors, Myths and Truths”

cancer.org/AboutUs/HowWeHelpYou/rumors-myths-and-truths

American Society of Clinical Oncology

“Cancer Myths”

cancer.net/patient/all+about+cancer/cancer.net+feature+articles/cancer+basics/cancer+myths

Society for Integrative Oncology (SIO)

“SIO Practice Guidelines”

http://www.integrativeonc.org/index.php/sio-publishes-2009-practice-guidelines

Related Videos
Image of Dr. Goy.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
1 expert is featured in this series.
Related Content